BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36242915)

  • 21. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by Hras
    Jolly LA; Massoll N; Franco AT
    J Clin Cell Immunol; 2016 Oct; 7(5):. PubMed ID: 27942419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.
    Jachetti E; Cancila V; Rigoni A; Bongiovanni L; Cappetti B; Belmonte B; Enriquez C; Casalini P; Ostano P; Frossi B; Sangaletti S; Chiodoni C; Chiorino G; Pucillo CE; Tripodo C; Colombo MP
    Cancer Immunol Res; 2018 May; 6(5):552-565. PubMed ID: 29523597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
    Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
    Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different alpha(2) adrenoceptor subtypes control noradrenaline release and cell firing in the locus coeruleus of wildtype and monoamine oxidase-A knockout mice.
    Owesson CA; Seif I; McLaughlin DP; Stamford JA
    Eur J Neurosci; 2003 Jul; 18(1):34-42. PubMed ID: 12859335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
    Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody profiling of monoamine oxidase A knockout mice, an autism spectrum disorder model.
    Syu GD; Sutandy FXR; Chen K; Cheng Y; Chen CS; Shih JC
    Brain Behav Immun; 2023 Jan; 107():193-200. PubMed ID: 36243286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
    Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
    PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
    Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
    Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells.
    Zhao H; Nolley R; Chen Z; Reese SW; Peehl DM
    Differentiation; 2008 Sep; 76(7):820-30. PubMed ID: 18248494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiomyocytes-specific deletion of monoamine oxidase B reduces irreversible myocardial ischemia/reperfusion injury.
    Heger J; Hirschhäuser C; Bornbaum J; Sydykov A; Dempfle A; Schneider A; Braun T; Schlüter KD; Schulz R
    Free Radic Biol Med; 2021 Mar; 165():14-23. PubMed ID: 33476795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos.
    Wang CC; Man GC; Chu CY; Borchert A; Ugun-Klusek A; Billett EE; Kühn H; Ufer C
    J Biol Chem; 2014 Mar; 289(12):8252-63. PubMed ID: 24497636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis.
    Kim WY; Won M; Salimi A; Sharma A; Lim JH; Kwon SH; Jeon JY; Lee JY; Kim JS
    Chem Commun (Camb); 2019 Oct; 55(88):13267-13270. PubMed ID: 31621760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.
    Inaba-Hasegawa K; Shamoto-Nagai M; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2017 Sep; 124(9):1055-1066. PubMed ID: 28577058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
    Wang K; Luo J; Yeh S; You B; Meng J; Chang P; Niu Y; Li G; Lu C; Zhu Y; Antonarakis ES; Luo J; Huang CP; Xu W; Chang C
    Nat Commun; 2020 Jun; 11(1):2689. PubMed ID: 32483206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
    Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
    Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
    Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.
    Shen L; Sundstedt A; Ciesielski M; Miles KM; Celander M; Adelaiye R; Orillion A; Ciamporcero E; Ramakrishnan S; Ellis L; Fenstermaker R; Abrams SI; Eriksson H; Leanderson T; Olsson A; Pili R
    Cancer Immunol Res; 2015 Feb; 3(2):136-48. PubMed ID: 25370534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.
    Dhabal S; Das P; Biswas P; Kumari P; Yakubenko VP; Kundu S; Cathcart MK; Kundu M; Biswas K; Bhattacharjee A
    J Biol Chem; 2018 Sep; 293(36):14040-14064. PubMed ID: 30021838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase: from genes to behavior.
    Shih JC; Chen K; Ridd MJ
    Annu Rev Neurosci; 1999; 22():197-217. PubMed ID: 10202537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.